Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 3, 2001, Pages 571-578

  Vordermeier, H M ^a   Whelan, A ^a   Cockle, P J ^a   Farrant, L ^a   Palmer, N ^a   Hewinson, R G ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; SYNTHETIC PEPTIDE; TUBERCULIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CATTLE DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CATTLE; DIAGNOSIS, DIFFERENTIAL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; PEPTIDES; TUBERCULOSIS, BOVINE;

EID: 0035008142     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.3.571-578.2001     Document Type: Article

References (57)

1. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10
2. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides
3. Field experiment with BCG vaccine in Malawi
4. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)
5. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle using recombinant mycobacterial antigens
6. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG
7. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae
8. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MBP83
9. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
10. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries
11. Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa
12. The bovine tuberculosis cycle - An African perspective
13. Mycobacterium bovis infections in San Diego: A clinico-epidemiologic study of 73 patients and a historical review of a forgotten pathogen
14. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig
15. EEC directive 80/219, amending directive 64/432 annexe B
16. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens
17. Soluble Mycobacterium bovis protein antigens: Studies on their purification and immunological evaluation
18. Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen
19. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG
20. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
21. Mycobacterium bovis in England and Wales: Past, present and future
22. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells
23. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines
24. Molecular characterization of MPT83: A seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70
25. Untersuchungen zur Tuberkuloseschutzimpfung bei Rindern
26. Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis
27. Lack of production of the 19-kDa glycolipoprotein in certain strains of Mycobacterium tuberculosis
28. T-cell recognition of mycobacterial proteins MPB70 and MPB64 in cattle immunized with antigen and infected with Mycobacterium bovis
29. Recognition of a common mycobacterial T-cell epitope in MPB59 of Mycobacterium bovis
30. Mycobacterial antigen-specific antibody responses in bovine tuberculosis: An ELISA with potential to confirm disease status
31. Therapy of tuberculosis in mice by DNA vaccination
32. Multi-rod peptide synthesis strategy for T cell determinant analysis
33. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues
34. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis
35. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis
36. Identification of bovine T-cell epitopes for three Mycobacterium bovis antigens: MPB70, 19,000 MW and MPB57
37. Peptide mapping of bovine T-cell epitopes for the 38 kDa tuberculosis antigen
38. Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle
39. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin
40. Antigen specificity in experimental bovine tuberculosis
41. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens
42. Analysis of the proteome of Mycobacterium tuberculosis in silico
43. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors
44. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle
45. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10
46. Towards the development of diagnostic assays to discriminate between Mycobacterium bovis infection and BCG vaccination in cattle
47. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle
48. Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test
49. T cell repertoire in tuberculosis: Selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease
50. Promiscuous T cell recognition of an H-2 IA-presented mycobacterial epitope
51. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
52. Peptide specific response to M. tuberculosis: Clinical spectrum, compartmentalization and effect of chemotherapy
53. In vitro immunodiagnostic assays for bovine tuberculosis